All Stories

  1. MHC class I in bladder cancer immunotherapy

    Article • International Journal of Cancer, November 2020, Wiley

    Malgorzata Garstka

  2. Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis

    Article • Oncotarget, November 2017, Impact Journals, LLC

    Malgorzata Garstka

  3. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Malgorzata Garstka

  4. Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Malgorzata Garstka

  5. An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport

    Article • Cell, June 2016, Elsevier

    Malgorzata Garstka

  6. The first step of peptide selection in antigen presentation by MHC class I molecules

    Article • Proceedings of the National Academy of Sciences, January 2015, Proceedings of the National Academy of Sciences

    Dr Anastassis Perrakis, Malgorzata Garstka

  7. Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility

    Article • The FASEB Journal, August 2011, Wiley

    Professor Martin Zacharias, Malgorzata Garstka

  8. EBV Protein BNLF2a Exploits Host Tail-Anchored Protein Integration Machinery To Inhibit TAP

    Article • The Journal of Immunology, March 2011, Oxford University Press (OUP)

    Malgorzata Garstka

  9. Calreticulin‐dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules

    Article • The EMBO Journal, October 2009, Springer Science + Business Media

    Malgorzata Garstka

  10. Controlled Intracellular Release of Peptides from Microcapsules Enhances Antigen Presentation on MHC Class I Molecules

    Article • Small, September 2009, Wiley

    Malgorzata Garstka

  11. Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation

    Article • The Journal of Immunology, February 2009, Oxford University Press (OUP)

    Malgorzata Garstka

  12. Peptide-receptive Major Histocompatibility Complex Class I Molecules Cycle between Endoplasmic Reticulum and cis-Golgi in Wild-type Lymphocytes

    Article • Journal of Biological Chemistry, October 2007, Elsevier

    Malgorzata Garstka

  13. Multifunctionalized Polymer Microcapsules: Novel Tools for Biological and Pharmacological Applications

    Article • Small, May 2007, Wiley

    Malgorzata Garstka